Home > Boards > US Listed > Medical - Drugs >

AIkido Pharma Inc (AIKI)

AIKI RSS Feed
Add AIKI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/21/2021 5:12:01 PM - Followers: 180 - Board type: Free - Posts Today: 0




https://aikidopharma.com/published-papers/

KPC-34

Kucera Paper A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms

Kucera Paper Lipid Nucleoside Conjugates for the Treatment of Cancer

Kucers & Pardee Paper Improving Nucleoside Analogs via Lipid Conjugation

Short Summary of KPC34

The Phospholipid Gemcitabine Conjugate, KPC34, is a Novel Treatment for Leukemia

Wake Forest School of Medicine Study Phospholipiddeoxycytidine analogue prodrugs for the treatment of cancer

DHA-dFdC

Short-term Toxicity Study of DHA-dFdC

Study of DHA-dFdC

Synthesis and Cytotoxic Activity of Two Novel 1-Dodecylthio-2-decyloxypropyl-3-phosphatidic Acid Conjugates with Gemcitabine and Cytosine Arabinoside

Investor Relations.

AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices,
but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual
and institutional investor includes stock price and history, upcoming events and presentations and financial documents.
AIkido Pharma Inc. is traded on the Nasdaq under the ticker symbol AIKI.

Overview.

AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.
The Spherix platform contains patented technology from leading universities and researchers and we seek to develop
our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University.
Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Our pancreatic treatment has shown positive preclinical results for inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.
The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms observed with the current standard of care.
In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.

https://ir.aikidopharma.com/stock-information/

$AIKI Spherix Incorporated, a biotechnology company,focuses on developing small-molecule anti-cancer therapeutics.
Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
The company's platform consists of patented technology from leading universities and researchers and in the process of developing an
innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at
Austin and Wake Forest University.
It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic
markers in people that indicate an increased risk of developing pancreatic cancer.
Spherix Incorporated was founded in 1967 and is based in New York, New York.

$AIKI
https://aikidopharma.com/
https://aikidopharma.com/about/
https://aikidopharma.com/portfolio/
https://aikidopharma.com/portfolio/aml-all/
https://aikidopharma.com/portfolio/pancreatic-cancer/
https://aikidopharma.com/scientific-advisory-board/
https://aikidopharma.com/published-papers/
https://ir.aikidopharma.com/

About
AIkido Pharma Inc. .
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.

The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and
we seek to develop our innovative drugs through strong partnership with world renowned institutions,
such as The University of Texas and Wake Forest University.


Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML),
and acute lymphoblastic leukemia (ALL). Our pancreatic treatment has shown positive preclinical results for
inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.


The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms
observed with the current standard of care. In addition,
we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.







https://www.otcmarkets.com/stock/AIKI/disclosure

https://www.otcmarkets.com/stock/AIKI/news

https://www.otcmarkets.com/stock/AIKI/security

https://www.otcmarkets.com/stock/AIKI/profile

https://www.otcmarkets.com/stock/AIKI/quote

https://www.otcmarkets.com/stock/AIKI/overview



*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.






 
AIKI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPEX News: AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board 02/03/2021 09:00:00 AM
SPEX News: Aikido Pharma Secures Early Interest in Next Generation Radiotherapy 02/01/2021 08:00:00 AM
News News Alert: Current Report Filing (8-k) 05/13/2021 09:01:14 AM
PostSubject
#8244   * * $AIKI Video Chart 04-21-2021 * * ClayTrader 04/21/21 05:12:01 PM
#8243   AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido georgie18 04/16/21 10:17:20 AM
#8242   AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ georgie18 04/07/21 09:25:54 AM
#8241   AIKI...$1.17...Bidding the Lower Band to the 20ma to georgie18 04/03/21 09:27:00 AM
#8240   AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&i georgie18 03/29/21 09:25:57 AM
#8239   $aiki $1.17 ? 0.0 (0.00%) Taurus69 03/28/21 02:57:47 PM
#8238   * * $AIKI Video Chart 03-24-2021 * * ClayTrader 03/24/21 05:49:51 PM
#8237   Do VMHG next. Heel Hulk 03/15/21 06:16:52 PM
#8236   * * $AIKI Video Chart 03-15-2021 * * ClayTrader 03/15/21 05:33:09 PM
#8235   https://www.stockwatch.com/News/Item/U-prNY08103-U!AIKI-20210312/U/AIKI[/ur antman 03/12/21 11:49:43 AM
#8234   Today should be good for AIKI antman 03/09/21 06:57:46 AM
#8233   Come on AIKI- for pete's sake! antman 03/05/21 02:35:42 PM
#8232   News out yesterday. Closed up. AIkido Pharma Inc. billionsmatter 03/02/21 07:55:45 AM
#8231   $aiki $1.19 v -0.04 (-3.25%) Taurus69 02/26/21 08:29:58 PM
#8230   AIKI mentioned in this Magic Mushroom article https://insiderfinancial.com/eight BugStocks_com 02/22/21 02:37:18 PM
#8229   On January 12, 2021, AIkido Pharma Inc., a nuclear profitz 02/22/21 11:19:04 AM
#8228   I think the big boys are here now. nathanial 02/21/21 06:05:18 PM
#8227   47mm shares from the offering. Be about 80mm BlindSquirrelFindsNuts 02/21/21 06:00:16 PM
#8226   Alkido Pharma Inc (AIKI) mick 02/21/21 05:49:52 PM
#8225   How can you R/S a stock with nathanial 02/21/21 05:49:00 PM
#8224   I saw in the filings they extended the nathanial 02/21/21 05:45:44 PM
#8223   There is a PR on my TOS TDA timmage 02/21/21 05:16:37 PM
#8222   Gan,I play it csndle by candle so we georgie18 02/21/21 08:04:11 AM
#8221   georgi18, Thanks for your TA on this.. Gan 02/20/21 08:35:03 PM
#8220   Is there any link, filing or PR stating nathanial 02/20/21 07:13:55 PM
#8219   10k @ 1.58 for me :) STOCKSnGLOCKS 02/19/21 11:23:14 AM
#8218   There was nearly a million totalled on the stockticks 02/18/21 08:56:24 PM
#8217   $AIKI 18k@$1.55, I have a feeling tomorrow should FROZENFLAME 02/18/21 06:00:28 PM
#8216   Added 25k shares $1.57 hope this goes well :) Stockz12345 02/18/21 03:20:20 PM
#8215   Took a position at 1.68. Watching to mopartuck 02/18/21 07:19:13 AM
#8214   * * $AIKI Video Chart 02-17-2021 * * ClayTrader 02/17/21 05:04:12 PM
#8213   * * $AIKI Video Chart 02-17-2021 * * ClayTrader 02/17/21 03:57:56 PM
#8212   With you D-bol 02/17/21 10:28:41 AM
#8211   75M for what!? They got like 3 - BluSkies 02/17/21 09:23:18 AM
#8210   AIKI...$1.70...back in here with a 10,000 share starter...will georgie18 02/17/21 07:09:30 AM
#8209   Don't see AIKI mentioned anywhere? antman 02/16/21 05:06:39 PM
#8208   Read it all looks like AIKI is getting billionsmatter 02/16/21 10:20:45 AM
#8207   AIkido Pharma Enters Into Letter Of Intent With VApopeye 02/16/21 08:55:09 AM
#8206   It's on the move pre-market. Amy predictions? 1.6200 billionsmatter 02/08/21 08:52:59 AM
#8205   $aiki $1.49 v -0.04 (-2.61%) Taurus69 02/06/21 06:46:40 PM
#8203   $AIKI great setup, maybe a great cancer Therapeutics 3antar 02/02/21 01:40:12 PM
#8202   News out today: AIkido Pharma Adds Inventor Dr. billionsmatter 02/02/21 10:26:39 AM
#8201   AIkido Pharma Setting Up to Be Major Player in billionsmatter 02/02/21 09:56:53 AM
#8200   Have you checked out Convergent Therapeutics, Inc? It's billionsmatter 02/01/21 10:47:10 AM
#8199   News Out AIKI: Aikido Pharma Secures Early Interest Finditdotcom 02/01/21 09:54:50 AM
#8198   AIKI...$1.70...in the P/M...NEW YORK, Feb. 1, 2021 /PRNewswire/ georgie18 02/01/21 08:17:18 AM
#8197   https://otcbb.swingtradebot.com/equities/AIKI N.Y. , NASDAQ mick 01/31/21 08:55:31 PM
#8196   * * $AIKI Video Chart 01-26-2021 * * ClayTrader 01/26/21 06:06:25 PM
#8195   Profit Alert: AIKI Rockets From Alert of $.84 billionsmatter 01/26/21 02:08:54 PM
#8194   Profit Alert: SPONF Rockets From Alert of $.009 billionsmatter 01/26/21 11:48:31 AM
PostSubject
Consent Preferences